Eremid Genomic Services is a genomics contract research organization.
Eremid Genomic Services has raised $3.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.
Eremid Genomic Services's investors include Coddle Creek Capital.
Eremid Genomic Services is headquartered in Kannapolis, United States.
Eremid Genomic Services is a genomics contract research organization.
Eremid Genomic Services is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eremid Genomic Services — Funding & Investors." VCBacked, June 26, 2023, https://www.vcbacked.co/company/eremid-genomic-services. Accessed September 30, 2026.
VCBacked. (2023). Eremid Genomic Services — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/eremid-genomic-services
{{cite web |title=Eremid Genomic Services — Funding & Investors |url=https://www.vcbacked.co/company/eremid-genomic-services |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated